615 related articles for article (PubMed ID: 32728221)
1. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
Laforge M; Elbim C; Frère C; Hémadi M; Massaad C; Nuss P; Benoliel JJ; Becker C
Nat Rev Immunol; 2020 Sep; 20(9):515-516. PubMed ID: 32728221
[TBL] [Abstract][Full Text] [Related]
2. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
Schönrich G; Raftery MJ; Samstag Y
Adv Biol Regul; 2020 Aug; 77():100741. PubMed ID: 32773102
[TBL] [Abstract][Full Text] [Related]
3. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
Chrousos GP; Meduri GU
Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524
[No Abstract] [Full Text] [Related]
4. Covid-19: Time for a paradigm change.
Buonaguro FM; Ascierto PA; Morse GD; Buonaguro L; Puzanov I; Tornesello ML; Bréchot C; Gallo RC
Rev Med Virol; 2020 Sep; 30(5):e2134. PubMed ID: 32618072
[No Abstract] [Full Text] [Related]
5. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
Yaqinuddin A; Kvietys P; Kashir J
Respir Investig; 2020 Sep; 58(5):419-420. PubMed ID: 32611518
[No Abstract] [Full Text] [Related]
6. N-acetylcysteine as a potential treatment for COVID-19.
Jorge-Aarón RM; Rosa-Ester MP
Future Microbiol; 2020 Jul; 15():959-962. PubMed ID: 32662664
[No Abstract] [Full Text] [Related]
7. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19.
Busch MH; Timmermans SAMEG; Nagy M; Visser M; Huckriede J; Aendekerk JP; de Vries F; Potjewijd J; Jallah B; Ysermans R; Oude Lashof AML; Breedveld PH; van de Poll MCG; van de Horst ICC; van Bussel BCT; Theunissen ROMFIH; Spronk HMH; Damoiseaux JGMC; Ten Cate H; Nicolaes GAF; Reutelingsperger CP; van Paassen P
Circulation; 2020 Nov; 142(18):1787-1790. PubMed ID: 32946302
[No Abstract] [Full Text] [Related]
8. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
Xu ZS; Shu T; Kang L; Wu D; Zhou X; Liao BW; Sun XL; Zhou X; Wang YY
Signal Transduct Target Ther; 2020 Jun; 5(1):100. PubMed ID: 32561706
[No Abstract] [Full Text] [Related]
9. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
10. Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections.
Sies H; Parnham MJ
Free Radic Biol Med; 2020 Aug; 156():107-112. PubMed ID: 32598985
[TBL] [Abstract][Full Text] [Related]
11. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
[No Abstract] [Full Text] [Related]
12. The type I interferon response in COVID-19: implications for treatment.
Lee JS; Shin EC
Nat Rev Immunol; 2020 Oct; 20(10):585-586. PubMed ID: 32788708
[TBL] [Abstract][Full Text] [Related]
13. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
Yeleswaram S; Smith P; Burn T; Covington M; Juvekar A; Li Y; Squier P; Langmuir P
Clin Immunol; 2020 Sep; 218():108517. PubMed ID: 32585295
[TBL] [Abstract][Full Text] [Related]
15. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
Saha A; Saha B
Rev Med Virol; 2020 Sep; 30(5):e2140. PubMed ID: 32686248
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy and SAR-COV-2: an available and potential therapy?
Abdel-Latif RG; Mohammed S; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
[No Abstract] [Full Text] [Related]
17. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
Theoharides TC
Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
[No Abstract] [Full Text] [Related]
18. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
Mozzini C; Girelli D
Thromb Res; 2020 Jul; 191():26-27. PubMed ID: 32360977
[No Abstract] [Full Text] [Related]
19. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
[TBL] [Abstract][Full Text] [Related]
20. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
Mastellos DC; Pires da Silva BGP; Fonseca BAL; Fonseca NP; Auxiliadora-Martins M; Mastaglio S; Ruggeri A; Sironi M; Radermacher P; Chrysanthopoulou A; Skendros P; Ritis K; Manfra I; Iacobelli S; Huber-Lang M; Nilsson B; Yancopoulou D; Connolly ES; Garlanda C; Ciceri F; Risitano AM; Calado RT; Lambris JD
Clin Immunol; 2020 Nov; 220():108598. PubMed ID: 32961333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
